Skip to content

인엑소플랫

  • About Us
    • Leadership
  • Our Science
    • Novel Cancer Therapy
    • Process
    • Development Strategy
  • Pipeline
    • Pipeline
    • IEP01
  • Newsroom
    • News
    • Story
    • FAQ
  • CDRO Service
    • About CDRO
    • BA Request for Proposal
    • PA Request for Proposal
  • English
  • About Us
    • Leadership
  • Our Science
    • Novel Cancer Therapy
    • Process
    • Development Strategy
  • Pipeline
    • Pipeline
    • IEP01
  • Newsroom
    • News
    • Story
    • FAQ
  • CDRO Service
    • About CDRO
    • BA Request for Proposal
    • PA Request for Proposal
  • About Us
    • Leadership
  • Our Science
    • Novel Cancer Therapy
    • Process
    • Development Strategy
  • Pipeline
    • Pipeline
    • IEP01
  • Newsroom
    • News
    • Story
    • FAQ
  • CDRO Service
    • About CDRO
    • BA Request for Proposal
    • PA Request for Proposal
  • About Us
    • Leadership
  • Our Science
    • Novel Cancer Therapy
    • Process
    • Development Strategy
  • Pipeline
    • Pipeline
    • IEP01
  • Newsroom
    • News
    • Story
    • FAQ
  • CDRO Service
    • About CDRO
    • BA Request for Proposal
    • PA Request for Proposal

Newsroom

News

  • 2023년 07월 13일

    인엑소플랫, IFEZ 바이오·헬스케어 공급사슬 특별관 참여

  • 2023년 06월 09일

    인엑소플랫, 엑소좀 기반의 면역항암제 개발로 인천 빅웨이브 상반기 지원 프로그램 스타트업 선정

« 이전 1 2
인엑소플랫 INEXOPLAT, Inc.

본사 경상북도 포항시 북구 흥해읍 한동로 558, 403호(한동대학교 창업보육센터)
기업부설연구소 인천광역시 연수구 송도과학로 32, M동 2704호 (송도테크노파크IT센터)
전화 032-215-2228  팩스 032-215-2229

COPYRIGHT © INEXOPLAT, Inc. All Rights Reserved.

  • Privacy Policy
  • Terms of Use
  • Contact Us